MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Alpha-synuclein"

  • 2026 International Congress

    Unraveling Kinase-Phosphatase Dysregulation in Parkinson’s disease Peripheral Blood Mononuclear Cells Through Targeted Transcript Analysis

    E. Basu, R. Banerjee, B. Biswas, S. Mondal, J. Rungta, S. Sengupta, J. Ganguly, D. Dutta, S. Mukherjee, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: To probe kinase-phosphatase dysregulation and peripheral biomarker potential in peripheral blood mononuclear cells (PBMCs) via LRRK2 (kinase), PPM1H and PP2A (phosphatases), LC3 (autophagy), and…
  • 2026 International Congress

    Modulatory effects of bacterial-derived serine protease on pathological α-synuclein fibrillation in vitro

    HJ. Yang, JI. Choi (Incheon, Republic of Korea)

    Objective: To investigate the modulatory effects of bacterial-derived proteins on the pathological aggregation of α-synuclein (α-syn) Background: Aggregation of α-syn into toxic oligomers and protofibrils…
  • 2026 International Congress

    Beyond the Spinal Tap: Diagnostic Accuracy of Alpha-Synuclein Seeding Amplification Assays (SAA) in Cutaneous and Ocular Biofluids – A Comparative Diagnostic Accuracy Review

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To evaluate the diagnostic performance of alpha-synuclein (a-syn) seeding amplification assays (SAA) in skin and tear fluid (TF) as non-invasive alternatives to cerebrospinal fluid…
  • 2026 International Congress

    Neuropsychiatric Symptom Evolution Over the First Decade of Biomarker-Defined Parkinson’s Disease

    I. Schoen, J. Wang, S. Xie, C. Caspell-Garcia, E. Mamikonyan, M. Stark, N. Dahodwala, A. Siderowf, R. Dobkin, M. York, D. Weintraub (Philadelphia, USA)

    Objective: To examine the evolution of neuropsychiatric symptoms (NPS) in biomarker-defined Parkinson’s disease over the first decade following diagnosis. Background: Parkinson’s disease (PD) is frequently…
  • 2026 International Congress

    Impact of Alpha-Synuclein Burden and Cellular Stress on GBA-PD Macrophage

    V. Lentini, G. Uras, D. Moreno-Martinez, S. Lucas, A. Pantaleo, D. Hughes (London, United Kingdom)

    Objective: This study explores how non-neuronal dysfunction drives the rapid progression of GBA-PD, aiming to identify therapeutic targets that restore protein degradation and cellular stability.…
  • 2026 International Congress

    Longitudinal α-synuclein Seed Amplification Assay Analysis of PPMI Participants

    L. Concha-Marambio, C. Gochanour, J. Yin, C. Farris, Y. Ma, D. Lafontant, T. Simuni, K. Marek, T. Tropea, D. Coughlin (Iowa, USA)

    Objective: To evaluate longitudinal consistency in the assessment of misfolded α-synuclein aggregates (syn-seeds) in cerebrospinal fluid (CSF) by α-synuclein seed amplification assay (synSAA). Background: synSAA…
  • 2026 International Congress

    Age-Dependent Peripheral Dissemination of α-Synuclein Seeds: Mechanistic Basis for Blood-Based Early Detection of Parkinson’s Disease

    K. Kuang (Guangzhou, China)

    Objective: To evaluate the diagnostic utility of serum α-synuclein (α-Syn) seed amplification assay (SAA) for early PD detection using preformed fibril (PFF)-induced mouse models and…
  • 2026 International Congress

    Discordant Siblings Reveal Determinants of Clinical Penetrance in GBA-Associated Parkinson’s Disease

    T. Filidei, SP. Caminiti, R. Malito, P. Mitrotti, R. Calabrese, R. Stiuso, L. Bandirali, L. Gallo, M. Costanzo, P. Di Martino, M. Picascia, A. Pichiecchio, G. Fabbrini, EM. Valente, M. Avenali (Pavia, Italy)

    Objective: To investigate clinical, neuropsychological, biomarker, and imaging differences between siblings carrying the same GBA1 variant but discordant for Parkinson’s disease (PD). Background: Variants in…
  • 2026 International Congress

    Molecular Profiling of Brain-Derived Extracellular Vesicles and Fluid Biomarkers in Parkinsonism: Distinct Signatures and Clinical Correlates in Progressive Supranuclear Palsy

    A. Roy, S. Brahmachari, A. Pantelyat, L. Rosenthal, V. Dawson, T. Dawson (Baltimore, USA)

    Objective: (1) To validate serum-based enrichment of neuronal (L1CAM+) and microglial (TMEM119+) EVs in PSP; (2) to characterize α-synuclein, tau, and inflammatory/autophagic mediators in EVs…
  • 2026 International Congress

    Seed Amplification Assay Is More Sensitive To Detecting α-Synuclein In Gut Biopsies Than Immunohistochemistry

    B. Killinger, J. Duvernay, S. Choi, S. Pritzkow, M. Pinho, P. Engen, M. Shaikh, L. Zhang, C. Neumann, M. Villanueva, D. Sanchez-Bass, L. Dibenedetto, M. Abdel-Mohsen, S. Green, L. Lagorio, S. Luo, R. Voigt, A. Sharma, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: Assess seed amplification assay (SAA) and immunohistochemistry (IHC) in peripheral gut mucosal biospecimens as PD diagnostics. Background: SAA detects misfolded alpha-synuclein (α-syn) aggregates across…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 70
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley